Is Concentrix Corp. overvalued or undervalued?

As of 31 October 2025, the valuation grade for Concentrix Corp. moved from fair to attractive, indicating a positive shift in its valuation outlook. The company is currently considered undervalued, supported by a P/E ratio of 11, a price-to-book value of 0.90, and an EV to EBITDA ratio of 5.71. In comparison, Genpact Ltd. has a P/E ratio of 14.38, while ADT, Inc. shows a P/E of 10.02, suggesting that Concentrix Corp. is priced more favorably relative to its peers.
Despite the attractive valuation, Concentrix has underperformed against the S&P 500, with a year-to-date return of -6.84% compared to the index's 16.30%. This performance highlights a potential disconnect between market perception and intrinsic value, reinforcing the view that Concentrix Corp. is undervalued.